Stem cell-based therapy for fibrotic diseases: mechanisms and pathways

Area of Science:

• Biomedical Science
• Regenerative Medicine
• Immunology

Background:

• Fibrosis is a pathological scarring process leading to organ failure, affecting major organs like lungs, liver, and heart, and is linked to high morbidity and mortality.
• Existing fibrotic disorders range from cosmetic scars to severe conditions like systemic sclerosis and idiopathic pulmonary fibrosis, often exacerbated by inflammatory responses and tissue damage.
• Current therapeutic options to halt or reverse fibrosis are limited, highlighting the urgent need for novel treatment strategies.

Purpose of the Study:

• To review various stem cell types investigated for anti-fibrotic effects.
• To discuss the challenges and limitations of clinical applications of stem cells in treating fibrosis.
• To summarize the mechanisms underlying tissue fibrosis and the pathways employed by stem cells to exert anti-fibrotic effects.

Main Methods:

• Literature review of studies on stem cell applications for fibrosis.
• Analysis of general and organ-specific mechanisms of fibrotic processes.
• Examination of proposed mechanisms by which stem cells attenuate fibrosis.

Main Results:

• Stem cells possess immunomodulatory and regenerative potential, showing promise as anti-fibrotic agents.
• Despite potent capabilities, the precise mechanisms and pathways through which stem cells impact fibrosis are not fully understood.
• Various stem cell types have been investigated, each with unique properties, challenges, and limitations for clinical use.

Conclusions:

• Stem cell therapy represents a potential therapeutic avenue for fibrotic diseases.
• Further research is crucial to elucidate the underlying mechanisms of stem cell-mediated anti-fibrotic effects.
• Understanding these mechanisms will facilitate the development of effective stem cell-based strategies to combat organ fibrosis.